Search results
2 Top Biotech Stocks to Buy for the Long Haul
Motley Fool· 1 year agoEquity markets are entirely unpredictable in the short run. The biotech industry is a great place to look for stocks that can survive down markets and be...
2 Dividend Kings to Buy and Hold Forever
Motley Fool· 2 years agoDividend stocks aren't just for investors looking for a reliable passive income stream. Companies that have a habit of rewarding their shareholders with...
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip
Motley Fool· 11 months agoDividend Kings are among the most steady corporations on the market. While many businesses don't...
2 Stocks Down More Than 6% to Buy Right Now
Motley Fool· 1 year agoIn fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and...
7 Best S&P 500 Stocks to Buy in July
InvestorPlace via Yahoo Finance· 2 years agoJuly may be an excellent time to purchase several of the best S&P 500 stocks. Tighter monetary policy from the Federal Reserve (Fed) combined with high...
Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now
Zacks via Yahoo Finance· 9 months agoJ&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma...
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
Motley Fool· 7 months agoCoca-Cola (NYSE: KO) is the world's largest non-alcoholic beverage company, selling drinks in more...
3 Warren Buffett Stocks That Should Beat the Market During a Recession
Motley Fool· 2 years agoWarren Buffett has weathered plenty of economic downturns during his decades of investing....
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
Motley Fool· 6 months agoDividend stocks are great because they offer you payments no matter how they perform -- and no...
2 Top Biotech Stocks to Buy Right Now
Motley Fool· 6 months agoIt's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market. Two worth a closer look today are Amgen...
